UnitedHealth Group Incorporated (NYSE:UNH) is Lincoln Capital Corp’s 6th Largest Position

Lincoln Capital Corp lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,052 shares of the healthcare conglomerate’s stock after selling 263 shares during the quarter. UnitedHealth Group accounts for 4.7% of Lincoln Capital Corp’s portfolio, making the stock its 6th biggest holding. Lincoln Capital Corp’s holdings in UnitedHealth Group were worth $9,504,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Robbins Farley bought a new stake in UnitedHealth Group during the third quarter valued at about $25,000. Richelieu Gestion SA bought a new position in shares of UnitedHealth Group in the fourth quarter worth about $26,000. CGC Financial Services LLC boosted its stake in shares of UnitedHealth Group by 1,000.0% in the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 50 shares during the period. NewSquare Capital LLC boosted its stake in shares of UnitedHealth Group by 340.0% in the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after acquiring an additional 51 shares during the period. Finally, Strategic Investment Solutions Inc. IL bought a new position in shares of UnitedHealth Group in the first quarter worth about $35,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Up 0.2 %

NYSE UNH traded up $0.83 on Wednesday, reaching $493.14. 2,653,123 shares of the stock traded hands, compared to its average volume of 4,102,408. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The company has a fifty day moving average price of $503.73 and a 200-day moving average price of $518.79. The company has a market cap of $454.64 billion, a price-to-earnings ratio of 20.66, a PEG ratio of 1.32 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $445.68 and a 12 month high of $554.70.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The business had revenue of $94.43 billion for the quarter, compared to the consensus estimate of $92.13 billion. During the same period last year, the business posted $5.34 EPS. The business’s revenue was up 14.1% compared to the same quarter last year. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 27.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were paid a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Analyst Ratings Changes

UNH has been the subject of a number of research reports. Piper Sandler dropped their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. HSBC reissued a “reduce” rating and set a $480.00 price target (down from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Stephens reissued an “overweight” rating and set a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a research note on Friday, January 19th. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Insider Buying and Selling

In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.